📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeted mitochondrial therapy using MitoQ shows equivalent renoprotection to angiotensin converting enzyme inhibition but no combined synergy in diabetes (2017)

First Author: Ward M

Attributed to: Mitochondrial oxidative damage and human diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-017-15589-x

PubMed Identifier: 29123192

Publication URI: http://europepmc.org/abstract/MED/29123192

Type: Journal Article/Review

Parent Publication: Scientific Reports

Issue: 1

ISSN: 2045-2322